Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers A > Headlines for Alkermes Inc. > News item |
Alkermes downgraded by Jefferies to hold
Alkermes Inc. was downgraded by Jefferies & Co. analyst David Windley to a hold rating from a buy, but the price target on the stock was maintained at $18 per share following news that the FDA has extended the review of Vivitrex - a once-monthly shot to treat alcoholism in development with Cephalon Inc. - to Dec. 30. Alkermes shares Wednesday were down $1.67, or 8.94%, at $17.00 on volume of 2,871,855 shares versus the three-month running average of 1,150,260 shares.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.